Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

NeuroRetina

Financiado

The eye as a window to the brain

Nocturne GmbH, founded in 2018, is a spin-off from the Charité – Universitätsmedizin Berlin, Germany developing software solutions to efficiently process retina image data for neurological applications at scale across devices usin... ver más

30/11/2022

NOCTURNE GMBH

75K€

Presupuesto del proyecto: 75K€

Líder del proyecto

NOCTURNE GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 1 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2022-11-30

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-EIE-2021-SCALEUP-01-03: Women TechEU

Innovación

Cerrada hace 3 años

0% 100%

1 Participantes

NOCTURNE GMBH

75.00K€ | Lider

Proyectos interesantes

UNLC13-1E-2399 Laboratorio de imagen médica 12K€ Cerrado

TED2021-130944B-C21 SURGERYAI-MODELS:INCORPORANDO HERRAMIENTAS DIGITALES E IA EN... 154K€ Cerrado

MATEDD MRI analysis tool for early detection of dementia 75K€ Cerrado

TIN2012-33116 INTEGRACION DE DATOS ANATOMICO-FUNCIONALES MEDIANTE MAPAS DE... 116K€ Cerrado

iScan Automated retinal scans for early detection of diabetic eye... 4M€ Cerrado

ADAPTE A novel and accurate emotion recognition system for real-tim... 4M€ Cerrado

Últimas noticias

25-11-2024: ECE En las últimas 48 horas el Organismo ECE ha otorgado 52 concesiones

25-11-2024: CMVAMADRID En las últimas 48 horas el Organismo CMVAMADRID ha otorgado 1 concesiones

25-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 6 concesiones

Duración del proyecto: 6 meses Fecha Inicio: 2022-05-24
Fecha Fin: 2022-11-30

Líder del proyecto

NOCTURNE GMBH

TRL 4-5

Presupuesto del proyecto 75K€

Descripción del proyecto Nocturne GmbH, founded in 2018, is a spin-off from the Charité – Universitätsmedizin Berlin, Germany developing software solutions to efficiently process retina image data for neurological applications at scale across devices using advanced AI-based analysis. The innovative and unique technology developed tackles one the current major challenges in healthcare, the rapidly increasing burden of brain diseases. With the increase of life expectancy and aging population neurological disorders are the leading cause of disability and the second leading cause of death worldwide. The greatest unmet needs are better, faster and more cost-effective diagnostic and monitoring tools that could be widely available and have the potential to detect these diseases at the earliest stage in order to delay disability and provide each patient with a personalized treatment. To address this the team of Nocturne identified two major opportunities, the use of the retina as a window to the brain, and an already established on the market hardware imaging technology, cost-effective, widely available with no burden for the patient that can capture retinal images in less than 5 minutes. With its product, Nocturne addresses customers in pharmaceutical research, academia, and clinical care. In Germany alone, more than 1 million patients suffer from relevant diseases like Multiple Sclerosis, Parkinson’s disease, and others. We estimate the annual market volume in Germany alone at 350 million€, in Europe at 2 billion€. At market entry, Nocturne product is a CE-certified local installable web service, which accepts data from standard retinal imaging devices. The data are then analyzed with Nocturne’s technology, and a report is generated for the physician. The pricing is based on a pay-per-analysis, a model commonly used, for example, in radiology. Our focus is by removing the technical barriers and by providing unique insights into the diseases to enable better disease management and patient care.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores